Valéry Moine

422 total citations
16 papers, 219 citations indexed

About

Valéry Moine is a scholar working on Immunology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Valéry Moine has authored 16 papers receiving a total of 219 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 6 papers in Molecular Biology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Valéry Moine's work include Phagocytosis and Immune Regulation (9 papers), Immunotherapy and Immune Responses (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Valéry Moine is often cited by papers focused on Phagocytosis and Immune Regulation (9 papers), Immunotherapy and Immune Responses (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Valéry Moine collaborates with scholars based in Switzerland, France and United Kingdom. Valéry Moine's co-authors include Krzysztof Masternak, Lucile Broyer, Nicolas Fischer, Sébastien Calloud, Marie Kosco‐Vilbois, Walter Ferlin, Elie Dheilly, Laura Cons, Zoë Johnson and François Rousseau and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Valéry Moine

14 papers receiving 215 citations

Peers

Valéry Moine

IMMUN

ONCOL

RNMI

PHYSI

Lucile Broyer Switzerland

Anne Papaioannou Switzerland

Sébastien Calloud Switzerland

Stephanie O. Dudzinski United States

Julie Jurczyluk Australia

Emine Gulsen Gunes United States

Vanessa Klapp United States

Tommaso Sconocchia Austria

Jim West

Felix L. Fennemann Netherlands

Lucile Broyer Switzerland

Valéry Moine

141 ×0.9

IMMUN

79 ×1.0

ONCOL

60 ×1.0

RNMI

52 ×1.0

30 ×1.0

PHYSI

Citations per year, relative to Valéry Moine Valéry Moine (= 1×) peers Lucile Broyer

Countries citing papers authored by Valéry Moine

Since Specialization

Citations

This map shows the geographic impact of Valéry Moine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Valéry Moine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Valéry Moine more than expected).

Fields of papers citing papers by Valéry Moine

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Valéry Moine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Valéry Moine. The network helps show where Valéry Moine may publish in the future.

Co-authorship network of co-authors of Valéry Moine

This figure shows the co-authorship network connecting the top 25 collaborators of Valéry Moine. A scholar is included among the top collaborators of Valéry Moine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Valéry Moine. Valéry Moine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Martin, Gaëlle, Laura Cons, Florence Depontieu, et al.. (2025). Tumor-dependent myeloid and lymphoid cell recruitment in genO-BRGSF-HIS mice: a novel tool for evaluating immunotherapies. Frontiers in Immunology. 16. 1624724–1624724.

Seckinger, Anja, Vanessa Buatois, Valéry Moine, et al.. (2024). Targeting CEACAM5-positive solid tumors using NILK-2401, a novel CEACAM5xCD47 κλ bispecific antibody. Frontiers in Immunology. 15. 1378813–1378813. 2 indexed citations

Moine, Valéry, Giovanni Magistrelli, Franck Gueneau, et al.. (2024). Generation of FcRH5xCD28 Bispecific Antibodies Synergizing with T-Cell Engagers for Enhanced Multiple Myeloma Treatment. Blood. 144(Supplement 1). 2796–2796. 1 indexed citations

Depontieu, Florence, et al.. (2023). Abstract 4139: Functional human myeloid cells in BRGSF-HIS humanized mice enables myeloid-directed therapy assessment. Cancer Research. 83(7_Supplement). 4139–4139. 1 indexed citations

Chauchet, Xavier, Laura Cons, Laurence Chatel, et al.. (2022). CD47xCD19 bispecific antibody triggers recruitment and activation of innate immune effector cells in a B-cell lymphoma xenograft model. Experimental Hematology and Oncology. 11(1). 26–26. 20 indexed citations

Moine, Valéry, Bruno Daubeuf, Vanessa Buatois, et al.. (2022). 752P Novel CEAxCD3 (NILK-2301) and CEAxCD28 (NILK-3301) κλ bispecific antibodies for next generation immunotherapy of CEA-expressing cancer. Annals of Oncology. 33. S888–S888. 1 indexed citations

Seckinger, Anja, Vanessa Buatois, Valéry Moine, et al.. (2022). 853 Novel CEAxCD47 (NILK-2401) and CEAxCD3 (NILK-2301) kl bispecific antibodies for multimodal immunotherapy of CEA-expressing solid cancer. Regular and Young Investigator Award Abstracts. A892–A892.

Hatterer, Eric, Xavier Chauchet, Françoise Richard, et al.. (2020). Targeting a membrane-proximal epitope on mesothelin increases the tumoricidal activity of a bispecific antibody blocking CD47 on mesothelin-positive tumors. mAbs. 12(1). 1739408–1739408. 33 indexed citations

Moine, Valéry, Xavier Chauchet, Lucile Broyer, et al.. (2019). Abstract A088: Selective blockage of the innate immune checkpoint receptor CD47 on mesothelin (MSLN) positive solid tumor cells via dual targeting bispecific antibodies alters the tumor microenvironment to control tumor growth. Cancer Immunology Research. 7(2_Supplement). A088–A088. 1 indexed citations

10.

Moine, Valéry, Lucile Broyer, Xavier Chauchet, et al.. (2018). Abstract 2770: Dual-targeting mesothelin/CD47 bispecific antibodies for tumor-directed blockade of CD47 in solid cancer. Cancer Research. 78(13_Supplement). 2770–2770. 1 indexed citations

11.

Dheilly, Elie, Valéry Moine, Gérard Didelot, et al.. (2018). Tumor-Directed Blockade of CD47 with Bispecific Antibodies Induces Adaptive Antitumor Immunity. Antibodies. 7(1). 3–3. 19 indexed citations

12.

Masternak, Krzysztof, Xavier Chauchet, Vanessa Buatois, et al.. (2017). Abstract B37: NI-1701, a bispecific antibody for selective neutralization of CD47 in B cell malignancies. Cancer Immunology Research. 5(3_Supplement). B37–B37. 4 indexed citations

13.

Dheilly, Elie, Valéry Moine, Lucile Broyer, et al.. (2017). Selective Blockade of the Ubiquitous Checkpoint Receptor CD47 Is Enabled by Dual-Targeting Bispecific Antibodies. Molecular Therapy. 25(2). 523–533. 116 indexed citations

14.

Masternak, Krzysztof, Zoë Johnson, Vanessa Buatois, et al.. (2015). Abstract B54: Antagonizing CD47-SIRP alpha interaction with a bispecific antibody: A novel cancer immunotherapy approach. Cancer Immunology Research. 3(10_Supplement). B54–B54. 1 indexed citations

15.

Johnson, Zoë, Anne Papaioannou, Lucie Bernard, et al.. (2015). Bispecific antibody targeting of CD47/CD19 to promote enhanced phagocytosis of patient B lymphoma cells.. Journal of Clinical Oncology. 33(15_suppl). e14016–e14016. 7 indexed citations

16.

Magistrelli, Giovanni, Pauline Malinge, Rami Lissilaa, et al.. (2010). Rapid, simple and high yield production of recombinant proteins in mammalian cells using a versatile episomal system. Protein Expression and Purification. 72(2). 209–216. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact